Kynam Capital Management, LP 2seventy Bio, Inc. Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,953,825 shares of TSVT stock, worth $22.4 Million. This represents 3.34% of its overall portfolio holdings.
Number of Shares
5,953,825
Previous 5,953,825
-0.0%
Holding current value
$22.4 Million
Previous $25.4 Million
25.29%
% of portfolio
3.34%
Previous 2.84%
Shares
3 transactions
Others Institutions Holding TSVT
# of Institutions
128Shares Held
47.8MCall Options Held
84.3KPut Options Held
53.7K-
Morgan Stanley New York, NY4.36MShares$16.4 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY4.22MShares$15.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.91MShares$14.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.73MShares$14 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.5MShares$9.39 Million0.17% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $142M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...